Proven strategies for managing rising premiums without sacrificing the quality of your benefits program.
Industry Insights
Controlling Employer Healthcare Costs
Rising healthcare costs are the single largest concern for employers managing benefits programs in 2026. With medical trend projected at seven to nine percent and pharmacy costs growing even faster, employers need a multi-faceted strategy that goes beyond simply shifting costs to employees through higher deductibles and copays. The most effective cost management approaches combine smart plan design, pharmacy benefit optimization, data-driven decision making, and alternative funding arrangements to bend the cost curve while maintaining a competitive benefits package that supports employee health and satisfaction.
Understanding What Is Driving Your Costs
Before implementing cost containment strategies, employers need a clear understanding of what is actually driving their healthcare spend. The answer varies significantly by organization based on workforce demographics, geographic distribution, plan design, and historical utilization patterns. A detailed claims analysis that breaks down costs by category, identifies high-cost claimants and conditions, and compares your utilization patterns to benchmarks is the essential starting point.
Pharmacy costs are the fastest-growing category for most employer plans, driven by specialty medications, biosimilar adoption rates, and the emergence of high-cost therapeutic classes like GLP-1 agonists. Understanding your pharmacy cost breakdown at the therapeutic class level, including unit costs, utilization rates, and rebate performance, reveals specific opportunities for intervention. Many employers discover that a small number of high-cost specialty prescriptions account for a disproportionate share of their total pharmacy spend, which points toward targeted clinical management strategies.
Musculoskeletal conditions, including back pain, joint replacements, and orthopedic surgeries, are typically the second or third largest cost category for employer plans. Cancer treatment costs, while affecting a smaller number of individuals, can be catastrophic at the individual claim level and increasingly drive large employer plan costs as treatment innovations extend survival but at dramatically higher per-patient expense. Mapping your cost drivers with this level of specificity enables targeted interventions rather than the blunt instrument of across-the-board cost shifting.
Plan Design Strategies That Reduce Cost Without Reducing Value
Effective plan design is about creating financial incentives that steer employees toward high-value care while preserving access to the services they need. The outdated approach of simply raising deductibles and copays each year eventually reaches a point of diminishing returns where employees defer necessary care, leading to worse health outcomes and higher downstream costs when conditions that could have been managed early progress to more expensive treatment stages.
Value-based insurance design aligns cost-sharing with the clinical value of services. Under this approach, preventive screenings, chronic disease management medications, and evidence-based treatments have low or zero cost-sharing to encourage utilization, while low-value services like advanced imaging for uncomplicated back pain or brand-name drugs with available generic equivalents carry higher out-of-pocket costs. This approach has been shown to improve medication adherence for chronic conditions by fifteen to twenty percent while reducing overall plan costs through avoided complications and hospitalizations.
Centers of excellence programs designate high-quality facilities for complex procedures like joint replacements, spinal surgeries, cardiac procedures, and cancer treatment. Employers that steer employees to these designated facilities through reduced cost-sharing or waived travel expenses benefit from negotiated bundled pricing, lower complication rates, and shorter recovery times. Some centers of excellence programs include a warranty provision where the facility covers the cost of any complications or readmissions within a defined period, providing additional cost certainty for the employer plan.
Pharmacy Benefit Optimization
Pharmacy costs represent the most actionable area of cost management for many employers. The pharmacy benefit chain from manufacturer pricing to PBM contracts to plan design to point-of-sale transactions contains multiple points where cost reduction is possible without compromising employee access to necessary medications.
PBM contract transparency is the foundation of pharmacy cost optimization. Many employers are locked into PBM arrangements with opaque pricing models that include spread pricing, where the PBM charges the plan more than it pays the pharmacy and retains the difference, and rebate retention, where the PBM keeps a portion of manufacturer rebates rather than passing them through to the plan. Moving to a pass-through pricing model with full rebate transparency, auditable MAC lists, and clear administrative fee structures can reduce pharmacy costs by ten to twenty percent for employers who have been operating under traditional opaque arrangements.
Clinical management programs including prior authorization for high-cost specialty medications, step therapy protocols that require trial of lower-cost alternatives before expensive brand-name drugs, and therapeutic substitution programs generate additional savings. For GLP-1 medications specifically, employers are implementing coverage policies that require documented medical necessity, completion of lifestyle modification programs, and ongoing monitoring of treatment response to ensure that these high-cost medications are being used appropriately and generating meaningful clinical outcomes.
Biosimilar adoption strategies are another significant opportunity. As more biosimilars receive FDA approval and enter the market for expensive biologic medications used in conditions like rheumatoid arthritis, cancer, and inflammatory bowel disease, employers that implement biosimilar-preferred formulary positions and incentive programs can capture substantial savings. The price differential between reference biologics and their biosimilar alternatives ranges from fifteen to forty percent, representing meaningful per-patient savings for conditions that require ongoing treatment.
Alternative Funding Arrangements
Employers with 100 or more employees are increasingly moving away from fully insured health plans toward self-funded or level-funded arrangements that provide greater control over plan design, access to claims data, and the potential for financial upside when claims experience is favorable. Understanding the spectrum of funding options and which approach aligns with your organization risk tolerance and financial capacity is an important strategic decision.
Self-funded plans allow the employer to pay claims directly as they are incurred, purchasing stop-loss insurance to protect against catastrophic individual claims and aggregate claims that exceed expected levels. The employer retains any surplus when claims are lower than projected and bears additional cost when claims exceed projections, subject to stop-loss protections. The financial advantage of self-funding comes from eliminating the insurance carrier profit and risk margin embedded in fully insured premiums, avoiding state premium taxes that apply to insured plans, and gaining access to detailed claims data that enables targeted cost management initiatives.
Level-funded plans offer a middle ground for employers that want the financial advantages of self-funding with more predictable monthly costs. Under a level-funded arrangement, the employer pays a fixed monthly amount that covers expected claims, stop-loss premiums, and administrative fees. If actual claims are lower than expected, the employer receives a refund or credit. If claims exceed the funded level, stop-loss insurance covers the excess. This structure provides the data transparency and plan design flexibility of self-funding while limiting downside financial risk, making it an attractive option for mid-size employers in the 50 to 200 employee range who are evaluating alternatives to fully insured arrangements.
The Role of Employee Engagement in Cost Management
Sustainable healthcare cost management requires employees to be active participants in their health and healthcare decisions. The most sophisticated plan design and purchasing strategies deliver limited value if employees lack the knowledge, motivation, and tools to make informed choices about their care. Investing in employee engagement is not a soft initiative; it is a measurable cost management strategy.
Health literacy programs that educate employees about how their health plan works, how to read an explanation of benefits, how to compare costs across care settings, and when to use telehealth versus urgent care versus the emergency room reduce low-value utilization and improve care navigation. Employees who understand the cost implications of their healthcare decisions are more likely to choose generic medications, select in-network providers, and use preventive services that catch conditions early before they become expensive to treat.
Wellness and prevention programs that incentivize healthy behaviors generate long-term cost savings even if the payback period extends beyond a single plan year. Biometric screening programs that identify early-stage chronic conditions, smoking cessation programs that reduce tobacco-related health costs, and weight management programs that address obesity-related comorbidities all have documented positive ROI when sustained over a multi-year time horizon. The key is designing programs that achieve meaningful participation rates through appropriate incentives, convenient access, and integration with the broader benefits program rather than standalone initiatives that employees ignore.
FAQ
Get Started
Tell Us About Your Team and Let's Build Better Benefits
Share a few details about your organization and our employee benefits specialists will reach out with a customized benefits strategy. No obligation — just expert guidance from a team that understands workforce management.
Ready to Elevate Your Benefits?
Our benefits specialists design programs that attract talent and protect your team. Let us build a package that works for your organization.